Market Tracker

10/30 7:05pm ET

Dynavax Technologies Corp (NASDAQ:DVAX)

1.69
Data as of Oct 30
 +0.01 / +0.60%
Today’s Change
1.10
Today|||52-Week Range
2.14
-13.78%
Year-to-Date

Today’s Trading

Previous close1.68
Today’s open1.68
Day’s range1.65 - 1.70
Volume1,935,132
Average volume (3 months)1,705,374
Market cap$441.6M
Dividend yield--
Data as of 3:59pm ET, 10/30/2014

Growth & Valuation

Earnings growth (last year)+7.32%
Earnings growth (this year)+11.05%
Earnings growth (next 5 years)--
Revenue growth (last year)+15.82%
P/E ratioNM
Price/Sales34.19
Price/Book2.37

Competitors

 Today’s
change
Today’s
% change
ITCIIntra-Cellular Thera...+0.08+0.53%
AMPHAmphastar Pharmaceut...-0.02-0.20%
FOLDAmicus Therapeutics ...+0.16+2.90%
RVNCRevance Therapeutics...+0.31+1.61%
Data as of 3:59pm ET, 10/30/2014

Financials

Last reporting dateOctober 31, 2014
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$11.3M
Annual profit (last year)-$66.7M
Net profit margin-593.01%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Eddie J. Gray
Senior Vice President-Operations &
Quality
David F. Novack
Corporate headquarters
Berkeley, California

Forecasts